Health Care Compliance Association's (HCCA) 2015 Healthcare Enforcement Compliance Institute
25 October 2015
Ms. Johnston’s presentation is titled, “Perspectives on DOJ Enforcement.” Ms. Waltz’s presentation is titled, “The Reverse False Claims Act: A Reversal of Fortune: Living with FERA and the 60-Day Refund Rule and Balancing Audit Results and Refunds.”
This session will address:
- Compliance: What DOJ is looking for when it subpoenas the company’s compliance records
- Parallel Proceedings: Understanding what cooperation means in parallel proceedings and what DOJ is looking for in parallel criminal and civil False Claims Act proceedings
- Enforcement Trends: Discussion of DOJ’s criminal and civil health care investigations with a focus on home health, hospice and ambulance cases
For more information and to register, please visit the HCCA’s website.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.